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ABSTRACT 
 
Yuanyuan Duan 
University of Pittsburgh, 2009 
Biomineralization, one of the most widespread processes in nature, uses polyanionic proteins to 
direct oriented crystal growth. In bone and dentin, this process is under precise control of the 
collagen template and the noncollagenous acidic phosphoproteins. These phosphoproteins 
function differently depending on their sizes and level of phosphorylation. 
The goal of this research is to investigate the in vitro phosphorylation as well as the 
phosphorylation in mammalian cells of two highly phosphorylated bone/dentin extracellular 
matrix proteins: dentin phosphophoryn (DPP) and dentin matrix protein 1 (DMP1). This data 
will be important to the general hypothesis, that the phosphorylation of non-collagenous proteins 
play a significant role in matrix mediated mineralization.  
Our data shows that the in vitro phosphorylation of DPP and DMP1 could be optimized 
by adjusting the phosphorylation reaction time, calcium concentration, and protein modification 
by assessing various forms (with or without the C or N terminal end). Following the in vitro 
phosphorylation, mass spectrometry analysis was used to identify the sites of phoshorylation. In 
addition, to identify the kinases involved in phosphorylating DMP1, cell lysates from cells that 
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have (MC3T3) and do not have (NIH3T3) the ability to mineralize their matrix and were isolated 
and analyzed by zymogram. Casein kinase II catalytic subunit was identified in addition to 
potential novel kinases responsible for DMP1 phosphorylation, some possible novel kinases for 
DMP1 were discovered by mass spectrometry. 
The second goal of this research is to assess if cells that have the ability to form a 
mineralized matrix will possess specialized kinases that can phosporylate these highly 
phosphorylated and acidic proteins.  To achieve this goal we over-expressed and purified DMP1 
from two cell types: 1) cells that have the ability to mineralize their matrix and 2) cells that do 
not possess the ability to mineralize their matrix.  The purified proteins were then analyzed by 
SDS-PAGE and mass spectrometry to quantify and determine the sites of phoshorylation.    
This study has expanded our knowledge on the mechanisms involved in the 
phosphorylation of DPP and DMP1 and provided the parameters to start assessing the role of 
phosphorylation on tissue mineralization. 
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NOMENCLATURE 
 
CID: Collision-induced dissociation 
CKI: Casein Kinase I  
CKII: Casein Kinase II  
DSPP: Dentin sialophosphoprotein  
DPP: Dentin phosphophoryn 
DSP: Dentin sialoprotein 
DGP: Dentin glycoprotein 
DMP1: Dentin matrix protein 1 
ESI: Electro spray ionization 
ETD: Electron transfer dissociation 
MALDI: Matrix-assisted laser desorption/ionization 
MS: Mass spectrometry 
NCP: non-collagenous proteins 
TCEP: Tris (2-carboxyethyl) phosphine 
TOF: Time of Flight 
IAA: Iodoacetamide  
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1.0  INTRODUCTION 
1.1 OVERVIEW 
Osteogenesis (the process of bone formation) and Odontogenesis (the formation and 
development of teeth) are very similar. During osteogenesis, the osteoblasts arise from the 
osteoprogenitor cells in the bone marrow; mature osteoblasts produce a layer of nonmineralized 
collagenous matrix, which is called osteoid layer. Odontoblasts arise from the dental 
mesenchymal cells and secret nonmineralized collagenous pre-dentin layer. Osteoid layer and 
pre-dentin layer mineralize leading to formation of bone and dentin tissues, respectively (Figure 
1). Mature bone and dentin are composed of 60% mineral, 30% organic matrix and 10% water 
(by weight); this organic matrix consists of 90% type I collagen and 10% non-collagenous 
proteins[1] .  Formation of pre-dentin and osteoid and their transformation process to dentin and 
bone are highly controlled by the cells.  
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Figure 1. Osteogenesis(left) and odontogenesis(right)  
During osteogenesis, the osteoblasts arise from the dental mesenchymal cells and secret the osteoid layer. During 
odontogenesis, odontoblasts arise from the dental mesenchymal cells and secret pre-dentin layer. 
(from: http://www.biyolojiegitim.yyu.edu.tr/k/ostblstm/pages/osteoblast_jpg.htm. and 
http://education.vetmed.vt.edu/Curriculum/VM8054/Labs/Lab17/Images/DIGL14.JPG) 
 
The biological control of mineralization requires regulation in time and space. This 
regulation involves extracellular organic matrices molecules which provide organized nucleation 
sites and entropic factors that control the nucleation and growth kinetics of crystal growth. Our 
knowledge of how the mineralization process is initiated and regulated is limited. However, the 
non-collagenous proteins (NCP) of bone/dentin are believed to play an important role in 
mineralization.  
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1.2 MINERAL FORMATION AND EXTRACELLULAR MATRIX 
Bone, dentin and cartilage are all calcified tissues, they function both structurally and 
physiologically. Structurally, calcified tissues provide the rigid elements of bone and tooth. 
Physiologically, calcified tissues play an essential role in the regulation of ion’ levels in body 
fluid by acting as storage for ions. The major ions that are primarily regulated by bone are 
calcium and phosphate. One of the areas of high interest in calcified tissue research is the 
biomineralization process in these hard tissues. 
   The major mineral in vertebrates hard tissues is calcium phosphate , in the form of 
calcium hydroxyapatite (Ca10 (PO4)6OH2) and amorphous calcium phosphate [2]. The body 
fluids are super-saturated in respect to calcium and phosphate, hence prone to spontaneous 
hydroxyapatite precipitation. Calcium phosphate precipitation is highly regulated by the cells, 
which prevent spontaneous precipitation in soft tissues and induce controlled mineral formation 
in bone and dentin; if the process is not properly regulated, the result could be too little or too 
much mineral-either of which can compromise health[3] . 
  The mineralization process in bone and dentin is regulated by cells. The cells produce 
an organic matrix rich in acidic macromolecules. This matrix controls all aspects of mineral 
formation, including crystal nucleation growth kinetics, crystal size, morphology and 
organization of the crystals in the tissue. There are two mechanism of nucleation: homogeneous 
and heterogeneous. Homogeneous nucleation is a process that involves only precursor solutions 
without any foreign material (such as proteins) while heterogeneous nucleation is a process with 
foreign material. For bone and dentin formation, it is believed that the mineralization occurs via 
heterogeneous nucleation process[4]. Many macromolecules (e.g. collagen, non-collagen 
proteins) play an essential role in the mineralization process. Collagen works as a structural 
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template whereas non-collagen proteins, acidic in nature and highly phosphorylated, strongly 
bind calcium[4] . 
 
 
1.3 EXTRACELLULAR MATRIX COLLAGEN 
Calcification of bone and dentin requires an extracellular matrix (ECM). Type I collagen is the 
major extracellular matrix protein, providing structural template for bone/dentin formation.  
ECM of bone and dentin contain mainly type I collagen and very limited other fibrillar collagens. 
Type I collagen, the most abundant collagen in the human body, is the major matrix protein in 
both bone and dentin. It is packed as a 2-D quarter-staggered arrangement and a 3-D quasi-
hexagonal assembly to construct the fibrillar matrix, providing structural scaffold [5]. Analysis 
suggests that the type I collagen and non-collagenous matrix provides a template of charged 
amino acids such as glutamic acid, aspartic acid, lysine, arginine, hydroxylysine and histidine. 
This template dictates mineral formation in verterbrate tissues[6]. As a scaffold and deposition 
space, type I collagen plays an essential role in nucleation for mineralization. 
1.4 NON-COLLAGENOUS PROTEINS 
Up to this point little is known about how mineralization is initiated and regulated. However, 
several macromolecules (Table 1) in the extracellular matrix are known to play a major role in 
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the initialization and regulation of mineral deposit. These macromolecules such as 
Osteonectin[7], Osteopontin[8], Dentin matrix protein 1[9], and Phosphophoryn[10] control the 
nucleation and crystal growth. These proteins are extremely negatively charged, rich in aspartic 
and glutamic acids, and serines which are often phosphorylated. The most studied family of non-
collagen proteins is the SIBLING protein family[11] . 
                Table 1 Major non-collagenous proteins in bone and dentin 
Proteins originating in bone  Proteins originating in dentin 
Bone Acidic Glycoprotein 75 (Bag 75) 
Bone Sialoprotein (BSP) 
Osteopontin (OPN, SPPI, 2ar,  
uropontin, Eta-1,  44 kDa phosphoprotein, 
66 kDa phosphoprotein, 69 kDa 
phosphoprotein [pp69])  
Osteonectin (SPARC, ON) 
Bone Gla Protein (BGP, Osteocalcin) 
Matrix Gla Protein (MGP) 
Decorin (PG II) 
Biglycan (PG I) 
DMP1 
DSPP (low levels) 
 
Dentin matrix protein 1 (DMP1) 
Dentin sialophosphoprotein (Dentin matrix 
DSPP) 
Dentin proteoglycans (D-PG I, D-PG II) 
Matrix Gla Protein (MGP) 
Bone Gla Protein (BGP, Osteocalcin) 
Osteopontin (OPN) 
Osteonectin (SPARC, ON) 
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1.5 SIBLING PROTEINS 
A family of non-collagenous proteins contains an RGD motif which can interact with cell-
surface integrins, and is termed Small Integrin-Binding Ligand, N-linked Glycoprotein 
(SIBLING). The proteins that belong to the SIBLING family are:   osteopontin (OPN), bone 
sialoprotein (BSP), dentin matrix protein 1 (DMP1), dentin sialophosphoprotein (DSPP) which 
gives rise to dentin phosphophoryn (DPP) and dentin sialoprotein (DSP), and matrix 
extracellular phosphoglycoprotein (MEPE) [12]. These proteins, expressed in both bone and 
dentin, are secreted into the extracellular matrix during bone/dentin’s formation and play a role 
in matrix mineralization. They interact with integrin receptors and mediate cell attachment and 
signaling. Their genes all are located in human chromosome 4q 21-23.  
           SIBLINGs are usually post-translationally modified by phosphorylation, glycosylation, 
sulphation, and proteolytic processing. Such post-translational modifications and the high levels 
of anionic amino acids make these proteins highly negatively charged; they can bind Ca2+ in 
solution or calcium hydroxyapatite[13], and were shown to have the ability to specifically bind 
collagen fibrils[14, 15]. Thus, these proteins may act as a linkage between the collagen fibril and 
mineral crystal. Some studies suggest that SIBLINGs undergo conformational changes from 
random coil to beta-pleated sheet and beta-turns in the presence of calcium [16, 17] . 
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Table 2 Post-translational modifications of Sibling Proteins [18] 
 Phosphate 
(Pi/mol) 
CHO 
contents 
N-Gly O-Gly SA TGCH Sulphation 
OPN 13 16.6% detected detected 7.3% detected detected 
BSP 5.85 50% detected detected 12% detected detected 
DSP 6 29.5% detected detected 9% unknown unknown 
HMW-DSP 10 detected detected detected detected unknown unknown 
DPP 209 unknown unknown unknown unknown unknown unknown 
DMP1-37K 12 unknown unknown unknown unknown unknown unknown 
DMP1-57K 41 unknown unknown unknown unknown unknown unknown 
           
1.5.1 Dentin Phosphophoryn (DPP) 
The most abundant (>60% weight) non-collagenous protein produced by odontoblasts is dentin 
phosphophoryn. Dentin sialophosphoprotein (DSPP) is a precursor protein and has been never 
isolated from dentin extract. It is rapidly proteolytically processed to 3 proteins right after 
synthesis: dentin sialoprotein (DSP), dentin glycoprotein (DGP) and dentin phosphophoryn (DPP) 
which is rich in DSS repeat units, possibly by MMP-2 and MMP-20 [19]. (Figure 2)  
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Figure 2. Genomic organization of the mouse DSPP gene 
 Dentin sialophosphoprotein is a precursor protein. The whole mouse DSPP gene contains 5 exons, 4 introns, 
promoter and untraslated region. Exons 2, 3 and 4 code for DSP and exon 5 codes for phosphophoryn 
 
 
Figure 3 Scheme of different forms of DPP 
The full sequence is full PP (exon 5). The black and red sequence is recombinant PP, the black sequence only we 
named it C-stop PP 
DPP is the most acidic protein known. It contains 143 aspartic acid, 20 glutamic acid and 
291 serine in the mouse sequence, account for greater than 80% of total 557 amino acids, 
recombinant DPP has a PI about 2.9 (non-phosphorylated form). Most of the serine residues can 
be phosphorylated (highly 400res/1000 or moderately 250res/1000 of all amino acids in rat 
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DPP)[20]. DPP has the highest affinity for Ca2+ among all the matrix proteins studied. DPP was 
shown to bind to the collagen fibrils at the mineralization front while binding to calcium[15]. 
Thus, the phosphate groups on DPP may play an essential role in mineralization formation by 
providing the interface linkage of collagen and crystals. 
1.5.2 Dentin Matrix Protein 1 (DMP1) 
DMP1 is another acidic extracellular matrix protein containing 64 aspartic acid, 77 glutamic acid 
and 115 serines out of total 503 amino acids. In comparison to DPP, DMP1 has a PI of 3.9. 
Sequence analysis shows that about 66 serines could be phosphorylated by casein kinase II and 
29 serines could be phosphorylated by casein kinase I. DMP1 gene is also located on 4q21. 
Unlike DPP, DMP1 is found in both mineralizing (dentin, skeleton)[8] and non-mineralizing 
tissues (brain, kidney and salivary gland)[21]. 
DMP1 is required for both odontogensis and osteogensis (Figure 4). DMP1 was firstly 
shown to participate in biomineralization in MC3T3 cells, overexpression of DMP1 accelerated 
cell differentiation to odontoblast and initiated mineralization[22]. DMP1 was also found closely 
associated with the formation of bone nodule[23]. In proliferating preosteoblasts, DMP1 is 
predominately unphosphorylated in the nucleus [9]. During osteoblast maturation it becomes 
phosphorylated, and then secreted to the cytosol and extracellular matrix, where it orchestrates 
mineralization.   This phosphorylation is believed to be catalyzed by a nuclear isoform of Casein 
Kinase II when Ca2+ surges into the nucleus [9]. Thus phosphorylation seems to play an essential 
regulatory role in DMP1 function. Besides mineralization regulator, DMP1 also act as a 
transcription regulator that initiates osteoblast differentiation [9]. 
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Figure 4 DMP1 is required for both osteogenesis and odontogenesis 
DMP1 is required for both osteogenesis and odontogenesis by controlling cell differentiation and 
maturation, as well as mineralization. Schematic from Qin et al. [24] 
 
         Similar to DSPP, full length DMP1 is cleaved to 2 functional fragments: 37kDa and 57kDa 
(Figure 5, 6). The uniformity cleavages at X-Asp bonds suggest a single responsible proteinase 
or a single proteinase group, which is still not known. Possible candidate include PHEX 
(phosphate-regulating gene with homologies to endopeptidases on X chromosome) proteinase 
[25], and BMP-1 (bone morphogenetic protein 1)/tolloid-like metalloproteinases [24]. These 
enzyme(s) are widely expressed and are not tissue specific.  
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Figure 5 DMP1 is cleaved into 2 fragments 
Full length DMP1 is cleaved at X-Asp bonds to 2 functional fragments: 37kDa (N-terminal) and 57kDa (C-terminal) 
fragments
 
 
Figure 6 Scheme of different forms of DMP1 
Total AA: 503. Signal peptide: 1-16aa. The whole sequence is called full DMP1; the c-terminal part with signal 
peptide is c-DMP1. Signal peptide is required for in vivo study. 
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1.6 PHOSPHORYLATION BY EUKARYOTIC PROTEIN KINASES 
The phosphorylation of critical seryl and threonyl by specific kinases is one of the most 
important post-translational modifications of SIBLING proteins. One of the largest groups of 
kinases is the eukaryotic protein kinases, which comprise a large superfamily of homologous 
proteins. They can transfer the gamma phosphate from ATP or GTP to the acceptor hydroxyl 
residue to generate phosphate monoesters. Based on the type of acceptor, there are two 
subfamilies: the protein-serine/threonine kinases which utilize aliphatic hydroxyl groups on 
serine and threonine; and the protein-tyrosine kinases which utilize the phenolic hydroxyl groups 
on tyrosine. Although there is a high diversity of structures and substrate specificities among 
different kinases, they all have catalytic domains which consist of approximately 250-300 amino 
acids, folding into a common catalytic core structure. 
      Among these eukaryotic protein kinases superfamily, casein Kinase I & II are messenger-
independent protein kinases. They are defined by the fact they can phosphorylate acidic 
sequences such as in casein. Their activities are not depending on any known second messengers.  
    Casein Kinase I (CKI) is a monomer with a molecular weight of 30kDa. For CKI 
phosphorylation, the most effective recognition motif is pSXXS/T where there is a Ser 
containing phosphate groups in the position -3 [26]. Also, if there are clusters of acidic residues 
at the position -3, D/EXXS/T phosphorylation can also occur. The preference of phospho-serine 
leads to so called hierarchical phosphorylation. Especially, in a SXXS sequence, the 
phosphorylation of first Serine helps the second Ser to be phosphorylated by CKI[27]. 
 Casein Kinase II (CKII) is a tetramer with an αα’β2 or α2β2 form. The molecular weight 
is 41kDa to 44kDa for α subunit, 37kDa to 42kDa for α’ subunit, and 24kDa to 26kDa for β 
subunit[27]. The α and α’ subunits are catalytic subunits, the β subunit is the regulatory subunit 
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with a potential metal-binding motif and can undergo N-terminal autophosphorylation. CKII can 
phosphorylate serine and threonine when there is a cluster of acidic amino acids or 
phosphoserine at position +3, S/TXXD/E or S/TXXpS[27]. As CKI, CKII also participates in 
hierarchal phosphorylation schemes. 
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2.0  HYPOTHESIS 
 
Non-collagenous proteins (NCP) of bone/dentin are rich in phospho-proteins that do appear to 
play a major role in initiation and regulation of the mineralization process. These phospho-
proteins possess a sequence rich in D and S which has the potential to be phosphorylated. 
Attention has been focused on studying the role of these proteins in mineralization, but the role 
of phosphorylation of these proteins and corresponding effects in mineralization is not 
understood. 
          The goal of this research is to elucidate the mechanisms involved in phosphorylating the 
highly phosphorylated proteins of bone and dentin,   Emphasis will be placed to phosphorylation 
of DPP and DMP1 since they are the most phosphorylated proteins in the bone/dentin 
extracellular matrix.  These data will be critical to prove the general hypothesis of our research 
that the phosphorylation level of non-collagenous proteins play a significant role in matrix-
mediated mineralization.  
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3.0  MATERIAL AND METHODS 
3.1 REAGENTS AND MATERIALS 
[γ- 32P] ATP of specific activity was purchased from ICN Biomedical Inc. Reagents for SDS-
polyacrylamide gel electrophoresis was obtained from Bio-Rad. Casein Kinases’ assay kit was 
obtained from Millipore. All other chemicals for phosphorylation assays, subcellular fractions 
and zymogram were purchased from Sigma. All medium for cell culturing are from GIBCO. 
3.2 RECOMBINANT PROTEIN PURIFICATION 
3.2.1 Constructs and mutation 
Several forms of DPP were used for in vitro phosphorylation as shown in figure 3, 
- Original recombinant PP (rPP) plasmid PGEX-4T-3-pp was cloned by Dr. Sfeir. This 
clone was designed to include the [DSS] repeats, but it lacked the N-terminal end of the 
protein. 
- C-stop rPP is made by inserting a stop codon to PGEX-4T-3-pp using Quikchange XL 
site-Directed Mutagenesis Kit (STRATAGENE Catalog # 200517) using the following 
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primers: Primer 1 (5' gttctgacagcagt tag ggtgacagcaagtctg 3’) and primer 2 (5' 
cagacttgctgtcacc cta actgctgtcagaac 3') (Table 3).  
Table 3 Cycles of PCR 
Segment Temperature Time cycles 
1 95°C                      1 minute 1 
 
2 
95°C                      50 seconds     
18 
60°C                       50 seconds    
68°C                       8 minutes (1 min / Kb of plamid) 
3 68°C                       7minutes                                                         1 
                           4°C                       
 
- Full length DPP (fPP) was generating by cloning the full length of exon 5 which includes 
the N-terminal end. (Figure 3).C-stop fPP is made using the same methods as C-stop rPP 
The C-terminal and full length DMP1 clones were obtained from Dr. Jian Feng’s Laboratory at 
Baylor school of Dental Medicine.  
All mutations (Figure 3) were confirmed by Sequencing in Proteomics & Genomics Core Lab, 
University of Pittsburgh. 
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3.2.2 Recombinant protein purification 
All clones were transformed into BL21 bacteria, and were cultured in autoclaved Luria Broth 
with 50ug/ml ampicillin, 37°C. Protein expression was induced by adding 0.1mM IPTG to 
cultured BL21 with an OD 0.8, then culture for another 4 hours. After 10,000 RPM 
centrifugation for 45min at 4°C in JA-12 rotor, bacteria (pellets) were collected and sonicated, 
treated with 1% Triton X-100, 0.06% beta-mercaptoethanol and 10mM MgCl2. GST sepharose 
4B beads. GST-tag protein was eluted in 10mM Glutathione, 1M Tris pH8.0 or further cleaved 
by biotinylated-thrombin.  
     Purified proteins were dialyzed in ddH2O using Amicon Ultra-15 Ultracel-10K (Millipore) 
and centrifuged at 5000g, 30min, 3 times. Protein concentrations were measured using a BCA kit. 
3.3 TISSUE CLUTURE OF CELLS 
MC3T3 were cultured in Minimum Essential Medium-alpha Medium. MDPC23 were cultured in 
alpha-modified medium. NIH3T3, Hela, 293 were cultured in DMEM. All media were 
supplemented with 10% fetal bovine serum, 10% L-Glutamine and 10% Penicillin-streptomycin.    
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3.4 DMP1 PURIFICATION FROM CELLS 
Cells were grown to 80% confluence in normal media, then serum free media was used, and 10ul 
of adenovirus-CMV-DMP1 (2x1012 pt/ml) per 150mm plate was added. The cells were 
maintained in culture for 48 to 96 hours, the cell media was collected, concentrated and buffer 
exchanged in 6M urea in 20mM Tris-HCl, using Amicon Ultra-15 Ultracel-10K (Millipore). 
Cells were trypsinized with 0.05% trypsin, 0.53mM EDTA (Gibco-BRL), then washed and 
collected in lysis buffer containing phosphatase inhibitor cocktail (50mM NH4HCO3, 5mM 
TCEP, 1mM EDTA, 1mM PMSF and protease inhibitor cocktail (5mM Sodium Orthovanadate, 
10mM NAF, 25mM beta-Glycerophosphate).  Homogenization was carried out on ice in a glass 
homogenizer at low speed 333 rpm (Glas-Col, LLC) for about 30 strokes. The cell lysate was 
then subjected to a exchange buffer to 6M urea in 20mM Tris-HCl.  
           The cell media or cell lysate in 6M urea, 20mM Tris-HCl were loaded onto ion-exchange 
column (HiTrapTM Q FF 5ml column from GE Healthcare) using an FPLC(AKTA primer plus 
from GE Healthcare). The gradient used to elute the proteins was 0.1M NaCl (Buffer A) to 1M 
NaCl (Buffer B) in 80min.  Fractions corresponding to each peak were collected and analyzed by 
SDS-PAGE and stains-all stain. 
                     Buffer A: 6MUrea in 20mM Tris-HCl+0.1M NaCl (pH=7.2)  
                     Buffer B: 6MUrea in 20mM Tris-HCl+1M NaCl (pH=7.2) 
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3.5 CELL CYTOSOLIC AND MEMBRANOUS FRACTIONS PREPARATION 
The MC3T3 /MDPC23 cells were collected (4X106 cells/flask), trypsinized with 0.05% trypsin, 
0.53mM EDTA(Gibco-BRL), washed and homogenized in a solution of 50mM Tris-Hepes 
pH7.4, 1mM EDTA, 10mM Manitol, 1mM Dithiothreitol, 1 pill of Complete Protease inhibitor 
cocktail tablets(Roche Applied Science). Homogenization was carried out on ice in a glass 
homogenizer at low speed 333 rpm (Glas-Col, LLC) for about 30 strokes. The homogenate were 
centrifuged at 1,000g for 20min to sediment the nuclei and cell debris. The low speed pellet 
(nuclei and cell debris) and supernatant were collected separately. The supernatant was further 
centrifuged at 100,000g for 30min to obtain the cytosolic and membranous fractions. All these 
fractions were stored at -80°C and thawed before their use for zymogram analysis or in vitro 
phosphorylation assays.  Figure 7 shows the cell fractionation scheme. We used supernant 2 for 
zymogram analysis and used pellet 1, pellet 2 and supernant 2 for in vitro phosphorylation 
assays. 
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Figure 7 Strategy for subcellular fraction  
The cells were collected and homogenized and centrifuged. The low speed pellet (nuclei and cell debris) and 
supernatant were collected separately. The supernatant was further centrifuged at 100,000g for 30min to obtain the 
cytosolic and membranous fractions.  
 
3.6 IN VITRO PHOSPHORYLATION 
3.6.1 In vitro phosphorylation by CKI and CKII 
The in vitro phosphorylation reaction was carried out in 40ul total volume,  containing 10ul 
assay dilution buffer I (20mM MOPS, pH7.2, 25mM beta-glycerol phosphate, 5mM EGTA, 
1mM sodium orthovanadate, 1mM dithiothreitol), 100ng Casein Kinase I or Casein Kinase II, 
dialysed protein substrate, ddH2O, 10µl 1µCi/µl Mg/ATP and [-32P] mixture.  The reaction 
solution was incubated for a range of time (30min to overnight) in a shaker incubator at 30°C or 
37°C. The controls consisted of carrying out the phosphorylation reaction with the enzyme only 
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(sample with enzyme but no protein substrate) and a protein only control (sample with protein 
substrate but no enzyme).  
3.6.2 In vitro phosphorylation by cell fractions  
Cell fractions were prepared as described in section 3.5. Insoluble fractions such as pellet 1, 
pellet 2 were treated with Triton X-100 at 4°C for 1hour, then the sample was centrifuged at 
1000g for 5min and then the supernatant was collected. The soluble fractions were added to the 
reaction solution directly. Each reaction tube contains 10ul ADBI buffer (Assay Dilution Buffer I 
as suggested by company), cell fractions, 10µl 1µCi/µl Mg/ATP and [γ-32P] mixture. The 
reaction solution was incubated for a range of time (30min to overnight) in a shaker incubator for 
30°C or 37°C.  
3.6.3 Phosphorylation quantification by scintillation counter  
            3.6.3.1 Measurement on P81 paper square 
 Upon completion of the phosphorylation reaction, 25 µl were transferred onto the center of a 
2cmx2cm P81 paper square. The radiolabeled solution was allowed to bind to the filter paper. 
The P81 paper square was washed 3 times with 40ml 0.75% phosphoric acid in a 50ml conical 
tube. The P81 paper was gently shaken for 5 minutes per wash on a rotator. Then the P81 paper 
was washed with 20ml acetone and shaken for 5 minutes. All washes were discarded in a liquid 
radioisotope waste container. The P81 paper square was then allowed to drain for 5 min and then 
transferred to a scintillation vial where 5ml scintillation cocktail was added and the radioactivity 
was quantified using a scintillation counter.     
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          3.6.3.2 Measurement using centrifugal filter devices 
 Upon completion of the phosphorylation reaction, the total volume was transferred to a 10kD 
microcon centrifugal filter devices (Millipore), ddH2O was added to a final volume of 200µl, 
then centrifuged at 14,000xg for 30min. The filter was washed again in 200µl ddH2O, 
centrifuged at 14,000 x g for another 30min. The filter device was removed from the eppendorf 
tube and placed directly into the scintillation vial. 5ml scintillation cocktail was added, and 
radioactivity was quantified in a scintillation counter.     
3.6.4 Phosphorylation detection by SDS-Gel 
Upon completion of the phosphorylation reaction, 8 µl of 6x Loading buffer (0.35M Tris-HCl 
PH6.8, 10.28% SDS, 36% glycerol, 0.6 MDTT, 0.012% Bromophenol blue) was added to the 
each 40 µl reaction sample and then boiled for 5min at 95°C. The samples were loaded on an 8% 
SDS-PAGE and run for 2hour at 100V. The gel was then dried on filter paper (Bio-rad) using 
Model 583 Gel Dryer (Bio-Rad) and exposed to Kodak X-Omat Blue XB-1 film to detect labeled 
bands.  
 23 
3.7 MASS SPECTROMETRY 
3.7.1 In gel digestion 
Typically, samples were run in an 8% SDS-gel at 90V for 30 minutes and then 120V for 90 
minutes. Following the staining and destaining procedures, gel bands of interest were excised 
and collected pieces in a 600 µl tube. 100 µl of 50% Acetonitrile, 50mM Ammonium 
bicarbonate were added, we made sure the gel were  well soaked, shook at room temperature for 
30 minutes, the washing step was repeated twice. Finally, we added 50 µl of 100% Acetonitrile, 
then shook the sample for 5min, and dry the gel in Speed Vac.  
The dried gel pieces were reduced in 100 µl of 2mM Tris (2-carboxyethyl) phosphine 
(TCEP), 25mM Ammonium biocarbonate (pH 8.0), and incubated for 15 minutes at 37°C. The 
gel pieces were then alkylated in 100 µL of 20 mM iodoacetamide, 25 mM ammonium 
bicarbonate (pH 8.0) and incubate for 30 minutes at 37°C in the dark. After reduction and 
alkylation, the supernatant was discarded, the gel band was washed three times with 200 µL of 
25 mM ammonium bicarbonate, and each time the sample was shaken for 30 minutes. Then 50 
µL of acetonitrile was added, shaken for 5 minutes and dried in a Speed Vac.  
The gel slice was digested with trypsin.  To allow the concentrated trypsin to diffuse into 
the gel slice, the gel was rehydrated in 10 µl from a stock solution of 0.02 µg/µl of Promega 
Sequencing grade modified trypsin in 10% Acetonitril, 40 mM NH4HCO3 pH 8 for 1 h on ice. 
The excess of  trypsin that hasn't been absorbed into the gel slice was removed,  the gel slice was 
then covered with 50 µl of 10% Acetonitril, 40 mM NH4HCO3 pH 8.0, and was placed in a 
shaker incubator at 37°C overnight. 
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The peptides generated from the trypsin digestion were extracted by transferring the 
supernatant to a fresh tube, adding 50µl of 50% Acetonitril, 5% Fomic acid to gel slice and 
shaking the samples for 30minutes at 37°C. This step was repeated twice to extract more 
digested material. The extracted samples were then dried in Speed Vac, then resuspended in 200 
µl H2O, to be dried a second time in the Speedvac to remove all ammonium biocarbonate and 
Acetonitrile. The digestion was finally cleaned by ziptipC18 if necessary.  
3.7.2 In solution digestion 
Protein samples were desalted using desalting column (Pierce), concentrated using a speedvac,  
add 25 mM ammonium bicarbonate to 40µl, sample is reduced by adding 1.2 µl of 100 mM 
TCEP (tris-2-carboxyethyl-phosphine) to 5mM final, shake for 15 minutes at 37°C. 0.88 µl of 
500 mM IAA (Iodoacetamide) was added to 10 mM final concentration and was shaken in the 
dark for 30 minutes. The remaining IAA was neutralized by adding 20 ul of TCEP stock, 
vortexed, spun, and incubated at room temp for 45 min.  Then added trypsin to sample ratio 
should be between 1:50 to1:20.  Digestion was allowed to incubate at 37°C overnight. Digestion 
was acidified by adding formic acid to stop the reaction and then dried in Speed Vac and cleaned 
by ziptipC18 if necessary. 
3.7.3 MALDI-TOF MS 
For MALDI-TOF-MS analysis, the peptides and CHCA matrix (a-Cyano-4-hydroxycinnamic 
acid, about 10 µg/ µl, in 50%ACN and 0.1% TFA) solutions were premixed in a small 
Eppendorf tube, spun down and mixed 3 times, and applied directly to the sample plate. Once the 
 25 
sample is applied to the sample support, the sample was allowed to air dry. Other matrix such as 
Trihydroxyacetophenone (THAP), 3, 5-Dimethoxy-4-hydroxycinnamic acid (sinapinic acid) 
prepared according to Voyager instruction were also used in this study. The samples were all 
analyzed using the Voyager DE Pro (ABI) or 4700 TOF TOF (ABI) instruments. 
3.7.4 LC-ESI MS 
For LC-ESI MS analysis, samples were dissolved in 0.1% formic acid, run through a C18 
column.  The buffer A contained 0.1% formic acid in water while buffer B contains 0.1% formic 
acid in acetonitrile. Experiments were conducted on LCQ-DECA-XP (ThermoFinnigan) and 
LTQ-XL (ThermoElectron) instruments. 
3.8 ZYMOGRAM 
3.8.1 Detection of the kinase activity after 1-Dimension SDS-PAGE 
The cell fractions were prepared as described in section 2.5, and mixed with 6X loading buffer 
(0.35M Tris-HCl PH6.8, 10.28% SDS, 36% glycerol, 0.6 MDTT, 0.012% Bromophenol blue). 
The mixture was electrophoresed on an 8% SDS-pollyacrylamide gel containing 60 µg/ml of 
DMP1.  The DMP1 protein was added to the SDS-PAGE prior to polymerization.  Following the 
sample electrophoresis at 100V for 2 hours in an 8x8 cm gel, the SDS was removed first by 
washing the gel in 100 ml 20% iso-propanol in 50mM Tris-HCl, pH8.0 for 1 hour, this step was 
repeated once. Then the gel was washed with 250ml of 50mM Tris-HCl, pH 8.0 containing 5mM 
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2-beta mercaptoethanol for 1 hour at room temperature. The enzyme within the gel was 
denatured by treating the gel with 100ml 6M HCl-Guanidine for 1 hour at room temperature, and 
this denaturing wash was repeated a second time. Following the denaturation of, the enzyme, the 
enzyme was renatured by five washes of 250ml 50mM Tris-HCl, pH 8.0 containing 5mM 2-β 
mercaptoethanol and 0.04% Tween 40 at 4°C for total 16 hours. 
             To detect the enzyme activity in the cell fractions, the gel was incubated overnight in 
60ml phosphate buffer solution, which contains 50mM Tris-HCl, pH7.4, 5mM MgCl, 10mM 
beta-glycerophosphate, 50µM ATP and 300µCi [-32P] ATP.  
             After incubation, the gel was washed in a buffer containing 5% trichloroacetic acid 
solution and 1% sodium pyrophosphate 7 times, until the radioactivity of the solution became 
negligible. The gel was then dried on filter paper (Bio-Rad) using Model 583 Gel Dryer (Bio-
Rad) and exposed to Kodak X-Omat Blue XB-1 film to detect labeled bands. Usually 3 hours or 
longer (overnight) exposure was required for detection. 
3.8.2 Kinase identification using mass spectrometry 
The radioactive gel was stored in -80°C for one month for the radioactivity to decay. The gel 
bands corresponding to labeled bands were excised, and then treated as described in section 2.7.1. 
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4.0  RESULTS AND DISCUSSION 
In order to study the level of phosphorylation of PP and DMP1, we generated different forms 
(Figure 3, Figure 6) of these two proteins as described in section 3.2.  
Full length DPP (fPP)  
Recombinant PP (rPP): the N-terminal sequence was deleted from the fPP. This protein is 
primarily made of the [DSS] repeats 
C-stop PP (cPP): the C-terminal sequence was deleted from rPP by inserting a stop codon 
following the DSS repeat sequence.   
 
In regards to DMP1, we studied the two different forms of DMP1 based on the identified 
cleavage site. [23]. The full length DMP1 is called fDMP1, and the c-terminal region with signal 
peptide is called cDMP1 which is where the phosphorylation sites are located.  
4.1 MASS SPECTROMETRY OF PP 
In order to study the phosphorylation of PP by mass spectrometry, we digested the 
unphosphorylated rPP first. For rPP, which has extensive DSS repeat, we used EXPASY to 
identify the enzyme lists which might be able to cleave rPP. (Table 4)  
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Table 4 List of enzymes and chemicals that might cleave rPP 
Enzymes can cleave  rPP #. of  Cleavages Positions  Cleavage sites 
Arg-C proteinase 1 5 Arg-C 
Chymotrypsin     Y, F, W (preferred) 
/L, M, H/A, D, E –C 
Clostripain 1 5 Arg-C 
Asp-N endopeptidase  ALL D   N - Asp 
Lys-N/Lys-C 4 53  70  415  427/5
4  71  416  428 
N-Lys/Lys-C 
Proteinase K 7 8  10  11  26  132 
250  457 
Y, F, W-C 
Hydroxylamine 2 44   431 Asn-Gly 
Trypsin 4 5  71  416  428 K,R-C 
Endo Glu-c 9 1  14  28  50  52 
56  69  283  449 
Glu-C 
NTCB (2-nitro-5-
thiocyanobenzoic acid) 
2 132  179 N-Cys 
Thermolysin 2 25  249 N-A,I,L,V,M,F 
D,E-Xcan’t be cleaved 
 Formic acid   ALL D   D-C (preferred) /N-D 
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           Based on the data shown in Table 4, we concluded that PP would be hard to digest/cleave, 
the numbers of enzymes/chemicals that can cleave PP were limited, and most of them can only 
cut very few sites. We tried all enzymes and chemicals listed in this table except the ones that 
display only one cleavage site (Thermolysin, Arg-C proteinase, Clostripain, Hydroxylamine) , or 
LysN/C which would produce peptide either too small or too large for mass spectrometry 
analysis. Figure 8 shows the SDS gel of fPP after digestion by proteinase K, chymotrypsin, asp-
N, Endo-GluC and Trypsin. The disappearance of protein band and appearance of some smaller 
bands suggest that the protein was digested. From this gel, we observed that AspN, proteinase K 
and formic acid (data not shown) completely cleaved fPP, while trypsin, chymotrypsin and endo-
GluC cleaved fPP to a certain extent. fPP was not cleaved at all by NTCB(data not shown) 
 
 
 
Figure 8 fPP cleaved by enzymes and chemicals  
AspN and proteinase K completely cleaved fPP, while trypsin, chymotrypsin and endo-GluC cleaved fPP to a 
certain extent. 
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Based on the SDS gel result, we digested rPP using trypsin, chymotrypsin, Endo-GluC 
separately or together. We also used asp-N, formic acid digestion at different time points, from 1 
hour to 18 hour. The digested protein was then analyzed by mass spectrometry using different 
matrices such as CHCA, THAP and SA, however, we couldn’t obtain any peptide signal from 
rPP. This might be due to the acidic nature of rPP which makes the peptide highly negative 
charged. Another possibility could be due to the improper peptide size following digestion, e.g, 
peptides produced by Asp-N are too small, and peptides produced by trypsin are too large. 
4.2 MASS SPECTROMETRY OF DMP1 
cDMP1, which is less acidic than rPP and contains more amino acids other than “DSS” repeat, 
have been successfully digested and analyzed.   Theoretically, the combination of 2 enzymes 
(Trypsin and AspN) can digest 95% of DMP1. Figure 9 and Figure 10 show cDMP1 digested by 
Trypsin/AspN and analyzed on ABI 4700 MALDI-TOF-MS. Peptides signal identified are 
labeled.  
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Figure 9 cDMP1 digested by trypsin 
Green labels represent numbers of DMP1 amino acids in identified fragments。Coverage: 31% 
Identified peptide Expected ms Observed ms Amino acid position 
GELTDSNSR 978.4 978.4 87-95 
SQESQSEQDSR 1280.5 1280.5 241-251 
SEEDSDSQDSSR 1341.5 1341.6 252-263 
ETQSDSTEDTASKEESR 1899.8 1899.8 96-112 
EPTSTQDSDDSQSVEFSSR 2101.8 2101.8 54-72 
SKEESNSTGSASSSEEDIRPK 2225.0 2225.1 264-284 
GDREPTSTQDSDDSQSVEFSSR 2430.0 2430.0 51-72 
SEESKGDREPTSTQDSDDSQSVEFSSR 2990.3 2990.1 46-72 
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Figure 10 cDMP1 digested by AspN 
Green labels represent numbers of DMP1 amino acids in identified fragments.Coverage:48% 
Identified peptide Expected ms Observed ms Amino acid position 
DSRKLIV 830.5 830.6 289-295 
DYRGELT 853.4 853.5 84-90 
DDPESTRS 906.4 906.4 25-32 
DIRPKNMEA 1089.5 1089.6 280-288 
DAYHNKPIG 1014.5 1014.5 296-304 
DTASKEESRSESQE 1582.7 1582.8 104-117 
DSSRSKEESNSTGSASSSEE 2060.8 2060.9 260-279 
DSQSVEFSSRKSFRRSHVSE E 2484.2 2483.0 63-83 
DSSSQEGLQSQSASTESRSQ ESQSEQ 2787.2 2787.2 223-248 
DGDSSSQEGLQSQSASTESRSQESQSEQ 2959.1 2959.3 221-248 
DPSSESSEEAGEPSQESSSESQEGVTSESRG 3172.3 3172.3 133-163 
DSPEGQDPSSESSEEAGEPSQESSSESQEGVTSESRG 3785.5 3785.6 127-163 
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4.3 IN VITRO PHOSPHORYLATION OF PP 
When we performed the in vitro phosphorylation of PP by CKI, we determined that the 
phosphorylation level detected using the scintillation counter technique is very low, e.g, only 
about 4 phosphates per molecule. When we determined the in vitro phosphorylation of both cPP 
and fPP using the scintillation counter, we obtained much higher phosphorylation levels than rPP 
(Figure 11) However, when we loaded the radio-labeled proteins on an SDS-PAGE, fPP showed 
less phosphorylation level than rPP while cPP still has higher levels of phosphorylation. These 
results suggest that PP might be too acidic to bind the negative charged P81 paper, the reason 
why fPP has higher level might due to stronger binding ability to P81 paper. The low binding 
might also be the reason of low phosphorylation level detected using scintillation counter. The 
low binding scenario was confirmed when we synthesized peptides based on the PP sequence 
that we then phosphorylated in vitro.  The acidic peptide with only DSS repeat couldn’t be 
detected by scintillation counter, whereas, the phosphorylation of the modified peptide with a 
basic N-terminus could be detected and quantified. 
          Since using the scintillation counter method to quantify the level of phosphorylation did 
not seem to be adequate we then decided to use a Microcon centrifugal filter device instead.  
Following three washes of the sample, the excess 32P[ATP] could not be removed which yielded 
a very high background. So far to determine the phosphorylation of PP is still unresolved.  
          Although we couldn’t quantify the total amount of phosphate or the number of 
phosphorylation sites using mass spectrometry, we used radioactive 32P[ [ATP] in combination 
with an SDS-PAGE to quantify the amount of phosphate using densitometry. The radioactive 
SDS-PAGE gel (Figure 12) shows that the cPP phosphorylation was enhanced compared to rPP 
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phosphorylation. Quantification by densitometry using Kodak 1D software (Figure 13) shows 
that the deletion of the c-terminus could enhance the phosphorylation level to about 1.5 times of 
rPP.  
The phosphorylation reaction was carried out by different enzymes kinases (Figure 14) 
shows that CKI could phosphorylate rPP much more than CKII, although sequence analysis 
suggest CKII is preferred than CKI; the combination of CKI+CKII did not show much 
phosphorylation enhancement. We also tested different time scales to phosphorylate rPP by CKI 
(Figure 15), the data shows that the phosphorylation level increases with longer incubation time. 
Based on these assay results, we used CKI to phosphorylate the c-stop PP and incubated 
it for 23 hour or longer to get higher phosphorylation levels in our related mineralization study. 
      
 
 
Figure 11 Comparison of in vitro phosphorylation of different PP forms 
Same mole amount rPP /fPP /c-stop PP are compared by scintillation counter.These differences might come from 
the different ability of different PP forms to bind to the P81 paper; it couldn’t represent the different phosphorylation 
level. The comparisons by SDS-gel below are more accurate. 
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Figure 12 In vitro phosphorylation of different PP forms by CKI 
Same mole amount rPP /fPP /c-stop PP phosphorylation level are compared by radioactive SDS-Gel. This method of 
relative comparison of PP phosphorylation might be more accurate than the scintillation counter method.  As the 
SDS-PAGE analysis circumvents the possible lack of PP binding to P81 paper needed for scintillation counter 
analysis. The phosphorylation level of cpp is higher compared to rpp and fpp. Fpp is the lowest. 
 
 
 
Figure 13 Quantified comparison of in vitro phosphorylation of different PP forms by CKI 
Same mole amount rPP /fPP /c-stop PP phosphorylation level are compared by radioactive SDS-Gel as in figure 12; 
these experiments are repeated 3 times and quantified by Kodak 1D software. 
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Figure 14 Comparison of rPP phosphorylated by different enzymes 
This data shows that CKI has the ability to phosphorylate rPP much more than CKII, although sequence analysis 
suggest CKII is preferred than CKI; the combination of CKI+CKII did not show a strong phosphorylation synergy 
between both enzymes. 
 
 
 
 
 
Figure 15 In vitro phosphorylation of rPP by different time scale 
In vitro phosphorylation of rPP by CKI yielded higher 32P incorporation onto rPP at longer incubation time when 
assessed by radiolabelled SDS-PAGE. Compared to 30min (normailized as 1), the phosphorylation level at 1h is 
1.69, 2h is 1.82, 3h is 1.94, 23h is 2.05. 
 
Since PP was proved difficult to analyze by mass spectrometry, we shifted our attention 
to DMP1 to study its phosphorylation and ultimately the effect of phosphorylation on 
mineralization.  
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4.4 IN VITRO PHOSPHORYLATION OF DMP1 
Our goal is to phosphorylate DMP1 and identify the phosphorylation sites in DMP1 with various 
levels of phosphorylation. We first study in vitro phosphorylation of fDMP1 and cDMP1 which 
both showed similar level of phosphorylation. We then decided to focus only cDMP1 
phosphorylation since it contains most of the phosphorylation sites. To optimize the in vitro 
phosphorylation of cDMP1, we assessed the phosphorylation level by using different conditions 
including temperature, type of enzyme, time, and Ca2+ concentration.        
         The phosphorylation reaction was carried out at 30ºC (the recommended temperature by 
the enzyme manufacturer) and 37ºC (body temperature of mice). The level of phosphorylation of 
cDMP1 at 30ºC and 37ºC remains the same when assessed by scintillation counter (Figure 16).   
            The phosphorylation reaction was also carried out using different enzymes, although 
sequence analysis shows that CKII would phosphorylate more sites than CKI (Figure 17), our 
data shows that CKI phosphorylated cDMP1 about 5 folds more than CKII.   
            The phosphorylation reaction was carried out at different time scales; Figure 18 shows 
that the phosphorylation level of cDMP1 increases with longer incubation time. 
The phosphorylation reaction was assessed at different calcium concentration, the 
increase of calcium, up to 2mM Ca++ seems to enhance the phosphorylation activity of CKI; if 
the calcium phosphorylation is >2mM then the  phosphorylation activity was reduced as shown 
in Figure 19. This enhancement under 2mM of Ca++ might be due to the confirmation change of 
DMP1 and the formation of DMP1-Ca complex[16, 17]. However, when higher calcium 
concentration were used (>2mM), this might trigger DMP1 polymerization, which might explain 
the decrease in the ability of the kinase to phosphorylate the protein.  
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The phosphorylation reaction was also assessed at different magnesium concentration; 
the phosphorylation level increase between 1mM to 10mM, higher (>30mM) Mg++ 
concentration inhibit the phosphorylation ability of the protein kinase, which might be due to the 
polymerization of the protein similar to the high Ca++ concentration (Figure 19). 
 
 
 
 
Figure 16 In vitro phosphorylation of cDMP1 at different temperatures 
The level of phosphorylation of cDMP1 at 30ºC and 37ºC (1 hour incubation) remains the same when assessed by 
scintillation counter 
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Figure 17 In vitro phosphorylation of cDMP1 by CKI and CKII 
CKI phosphorylated cDMP1 about 5 folds more than CKII when assessed by scintillation counter. 
 
 
Figure 18 In vitro phosphorylation of cDMP1 at different time points  
In vitro phosphorylation of cDMP1 by CKI shows higher phosphorylation level with longer incubation time 
assessed by radiolabelled SDS-PAGE. Compared to 30min (normailized as 1), the phosphorylation level at 1h is 
1.50, 2h is 1.51, 3h is 1.68, 23h is 1.85. 
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Figure 19 In vitro phosphorylation of cDMP1 with different Ca2+ (upper) or Mg2+ concentration 
The phosphorylation reaction was assessed at different calcium concentration, the increase of calcium, up to 2mM 
Ca++ enhances the phosphorylation activity of CKI; if the calcium phosphorylation is >2mM then the 
phosphorylation activity was reduced. One way ANOVA suggests the phosphorylation level with 2mM Ca++ is 
significantly higher (P= 0.08) compared to the group without Ca++.(Assessed by radiolabelled SDS-PAGE); At 
different magnesium concentration; the phosphorylation level increase between 1mM to 10mM, higher (>30mM) 
Mg++ concentration inhibit the phosphorylation ability of the protein kinase. (Assessed by pro-Q stained SDS-
PAGE) 
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         Determination of protein phosphorylation by Mass spectrometry is a challenging technique. 
ESI (Electro spray ionization) is usually a more sensitive method than MALDI (Matrix-assisted 
laser desorption/ionization). This is due to the weak signal from phospho-peptides; it is difficult 
to obtain good ms/ms spectra using MALDI.  On the other hand one advantage of the ESI 
method is that the phospho-peptides are separated from other peptides by using Liquid 
Chromatography prior to detection, which reduce the interference from the large excess of other 
peptides and enrich for the phospho-peptides. ESI has also some shortcomings, 1) large 
phospho-peptides are not easily eluted from the LC column 2) small  phospho-peptides are 
eluted very early with salt which largely compromised the quality of MS spectra 3)
H3PO4 is easily lost in ion trap of any MS machine, which makes it more difficult to identify the
phospho-sites.  
              In our experiment, we combined both MALDI and ESI to obtain more phospho-peptide 
information. Data from 4700(MALDI, CID) mass spectrometry analysis of cDMP1 
phosphorylated by CKI show 6 phospho-peptides (Figure 20, Table 5); data from LTQ-XL (ESI, 
ETD) (Figure 21) and LCQ-Deca-xp (ESI, CID) (Figure 22) confirmed some of these phospho-
peptides and also identified Ser66 as phospho-serine (Figure 22).  
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Figure 20 MS of phosphorylated cDMP1 (phospho-peptides circled) 
4700 mass spectrometry analysis detected 6 phospho-peptied (circled in Figure 20 and listed in Table 5) from 
cDMP1 phosphorylated by CKI. 
 
 
 
 
 
 
 
 
 
 
 
 43 
 
Table 5 Phospho-peptide of in vitro phosphorylated cDMP1 detected by MS  
(M-MALDI, E-ESI) 
Sequence mass position Method Missed 
cleavage 
SEEDSDSQDSSR 1341.5037 252-263 M 0 
SKEESNSTGSASSSEEDIRPK 2225.0164 264-284 M 1 
GDREPTSTQDSDDSQSVEFSSR  2430.0287 51-72 M,E 1 
SQESQSEQDSRSEEDSDSQDSSR  2603.0208 241-263 M,E 1 
SEESKGDREPTSTQDSDDSQ 
SVEFSSR  
2990.2729 46-72 M,E 2 
SESQEDTAESQSQEDSPEGQ 
DPSSESSEEAGEPSQESSSE 
SQEGVTSESR  
5264.0780 113-162 M 0 
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Figure 21 Phosphor-peptide 3071(1023.85*3) by LTQ-ESI MSn 
(Upper right) MS2 of a peptide ion at m/z 1023.85 – little in terms of fragmentation information due to the 
predominant neutral loss of H3PO4.Neutral Loss Dependent MS3 – 991.8 is “re-selected” for fragmentation (i.e. 
MS/MS/MS) producing significant sequence information to identify: SEESKGDREPTSTQDSDDSQSVEFSSR. 
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Figure 22 Phospho-peptide 2510(838.32*3) by LCQ-ESI MS2 
Sequence identified: GDREPTSTQDSDDSQSVEFSSR, y7(891.4) is a phospho-fragment while y6(724.3) is a non-
phospho-fragment. 891.4 to 792 show a neutral loss of H3PO4. 
 
 
 
 
 
4.5 ZYMOGRAM 
Sequence analysis and previous studies have showed that CKII-like enzyme from the nucleus 
can phosphorylate DMP1; however, no direct identification of CKII was reported to date. Since 
we couldn’t fully phosphorylate DMP1 using CKII in vitro, and considering the hierarchal 
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property of CKII, we hypothesized that CKII or other enzymes could phosphorylate DMP1 in 
vivo. 
             Firstly, we performed in vitro phosphorylation and confirmed that cellular fractions 
could phosphorylate cDMP1 (Figure 23).We collected cell lysates from MC3T3 (osteoblast), 
MDPC23 (odentoblast), NIH3T3 (fibroblast) and performed zymograms to find the 
corresponding enzyme band(s) that can phosphorylate DMP1. All 3 samples showed 3 bands 
exactly at the same positions (Figure 24). This zymogram experiment was repeated once. We 
concluded that there is no significant difference of kinases responsible for fDMP1 in 
mineralizing tissues versus non mineralizing tissues. At least 3 enzymes could phosphorylate 
fDMP1 in these cell lines, with molecular weight around 37, 40, and 60kDa, respectively. The 
radioactive bands were excised and analyzed by mass spectrometry; the lists of identified 
proteins included many protein kinases. DMP1 was also identified during the mass spectrometry 
analysis confirming that our digestion worked well. The 37kDa and 40kDa bands (because the 
gel is dried for imaging, it is hard to cut these two bands separately) have been analyzed by both 
4700 MALDI-TOF and LTQ, while the 60kDa band was analyzed only by 4700.The total list of 
enzymes will be identified once we obtain the result of 60kDa band from LTQ.  
            CKII catalytic subunit alpha was identified in MC3T3 cell lysis corresponding to 5 
peptides found, Figure 25, 26 show 2 ms/ms spectra of CKII subunit alpha peptides with high 
confidence. Although previous study[28] and sequence analysis suggested that CKII is the kinase 
that phosphorylate DMP1 in vivo, our research is the first direct evidence of CKII’s involvement. 
We tested the following kinases: Cell division protein kinase 6 and cAMP-dependent protein 
kinase (only part of the sequence is available) for their ability to phosphorylate DMP1 but none 
of them showed this ability. The other kinases in the list were not commercially available. 
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Figure 23 cDMP1 phosphorylated by cellular fractions 
 In vitro phosphorylation confirmed that cellular fractions could phosphorylate cDMP1, the level is very low 
compared to CKI, the difference didn’t mean the difference of phosphorylation level, but might only be 
experiments’ error. 
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Figure 24 fDMP1 zymogram  bands 
Upper panel: At least 3 bands were identified as being able to phosphorylate fDMP1 in these cell lines, with 
molecular weight around 37, 40, and 60kD. Lower panel: shorter exposure time picture to show the 2 bands. 
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Table 6 List of kinases found in MC3T3 cell lysis’ zymogram bands (37 and 40KD) 
UniProt Acc  # of peptides  Protein  
Q9Z1Z2  23  Serine-threonine kinase receptor-associated protein 
Q9QZ08  17  N-acetyl-D-glucosamine kinase OS=Mus musculus  
Q64261  6  Cell division protein kinase 6 OS=Mus musculus  
Q80UL3  5  Galactokinase 1 OS=Mus musculus  
O54833  5  Casein kinase II subunit alpha' OS=Mus musculus  
Q8K183  4  Pyridoxal kinase OS=Mus musculus  
P52332  3  Tyrosine-protein kinase JAK1 OS=Mus musculus  
Q61846  2  Maternal embryonic leucine zipper kinase, OS=Mus musculus  
Q61526  2  Receptor tyrosine-protein kinase erbB-3 OS=Mus musculus  
P52480-1  2  Isoform M2 of Pyruvate kinase isozymes M1/M2  
P05132-1  2  Isoform 1 of cAMP-dependent protein kinase catalytic subunit 
alpha OS=Mus musculus  
O09110-1  2  Isoform 2 of Dual specificity mitogen-activated protein kinase 
kinase 3 OS=Mus musculus  
The analysis is using Sequest, whose algorithm is matching experimental peptide to known fragmentation patterns 
of theoretical peptides. The protein abundances or presence were determined by # of peptide identified (as in column 
2). All proteins listed in this table have been confirmed by looking into their peptides’ spectra (as in Figure 25, 26) 
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Figure 25 MS/MS spectrum of peptide from CKII subunit alpha: VYAEVNSLR.  
Ions series matched are labeled in red (b ions) or blue(y ions). 
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Figure 26 MS/MS spectrum of peptide from CKII subunit alpha: HLVSPEALDLLDK 
Ions series matched are labeled in red (b ions) or blue(y ions). 
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Table 7 List of kinases found in MDPC23 cell lysis’ zymogram bands(37 and 40KD) 
UniProt Acc  # of peptides  Protein  
P52480-1  49  Isoform M2 of Pyruvate kinase isozymes  
M1/M2 OS=Mus musculus GN=Pkm2  
P09411  18  Phosphoglycerate kinase 1 OS=Mus musculus 
GN=Pgk1  
P05132-1  4  Isoform 1 of cAMP-dependent protein kinase catalytic  
subunit alpha OS=Mus musculus  
Q7TNL3-1  2  Isoform 1 of Serine/threonine-protein  
kinase 40 OS=Mus musculus  
Q80UL3  2 Galactokinase 1 OS=Mus musculus  
P20444  2  Protein kinase C alpha type OS=Mus musculus  
P12382  2  6-phosphofructokinase, liver type OS=Mus musculus  
Q61846  2  Maternal embryonic leucine zipper kinase  
Q99N57-1  2  Isoform 1 of RAF proto-oncogene serine/threonine-
protein kinase OS=Mus musculus  
Q924C5  2  Alpha-protein kinase 3 OS=Mus musculus  
The analysis is using Sequest, whose algorithm is matching experimental peptide to known fragmentation patterns 
of theoretical peptides. The protein abundances or presence were determined by # of peptide identified (as in column 
2). All proteins listed in this table have been confirmed by looking into their peptides’ spectra (as in Figure 25, 26) 
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4.6 MAMMALIAN CELL DERIVED DMP1 
Due to the high level of phosphorylation of DPP and DMP1, we hypothesized that the kinases 
present in mineralizing tissues such as bone and dentin would be different than the kinases 
present in non-mineralizing tissues. In order to compare the level of phosphorylation of DMP1 in 
mineralizing versus non mineralizing tissues, we over-expressed fDMP1 into cells that originated 
from mineralized tissues such as MC3T3 or U2OS cells or from connective tissue cells such as 
NIH3T3 or HEK-293 using an adenovirus that bare mouse fDMP1. We couldn’t over-express 
DMP1 gene from NIH3T3 cells after trying several different conditions, which might indicate 
some degradation mechanism in fibroblast cells. MC3T3, U2OS, HEK-293 all are originated 
from tissues where DMP1 was found. The secreted DMP1 was purified by ion exchange (Figure 
27) and confirmed by western blot (antibody from Dr. Qin). The comparison of DMP1 from 
MC3T3 versus HEK293 shows mostly similar but a little bit different cleavage and 
phosphorylation patterns (Figure 28). More 57kD and 37kD functional fragments were found in 
MC3T3 derived DMP1. DMP1 from U2OS, another bone derived cell was also phosphorylated. 
Our mass spectrum data (Figure 29-33) confirmed that we did purify DMP1 but did not provide 
phospho-peptide information from the cell derived fDMP1. This might be due to difficulty to 
detect phospho-peptide, or due to the possibility that phosphorylated amino acids are located in 
clusters which also occurs in OPN [29] and are hard to analyze by mass spectrometry. 
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Figure 27 U2OS derived fDMP1 purified by ion exchange. 
U2OS derived fDMP1 was purified by ion exchange, the largest peak is FBS; the small peak circled is DMP1. 
Fractions 19-22 were collected. 
 
 
 
Figure 28 MC3T3/ HEK293 derived DMP1 purified by ion exchange column 
DMP1 purified from MC3T3 (left) and HEK293 (right) cell medium. The blue bands (stains-all) and bright bands 
(pro-Q stain) are DMP1. DMP1 from these two cell lines have mostly similar but a little bit different cleavage and 
phosphorylation patterns. 
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Figure 29 293 derived fDMP1 digested by trypsin. Coverage:31% 
Identified peptide Expected 
ms 
Observed ms Amino acid 
position 
GQYRPAGGLSK 1133.6 1133.6 80-90 
ETQSDSTEDTASK 1398.6 1398.7 429-439 
ETQSDSTEDTASK 1398.6 1398.7 284-296 
GHARMSSAGIRSEESK 1702.8 1703.8 223-238 
SKEESNSTGSASSSEEDIRP K 2225.0 2225.1 452-472 
GDREPTSTQDSDDSQSVEFS SR 2430.0 2430.1 239-260 
SEESKGDREPTSTQDSDDSQ SVEFSSR 2990.3 2990.4 234-260 
VGGGSEGESSHGDGSEFDDE 
GM(O)QSDDPESTR 
3173.2 3173.3 189-219 
MKTVILLVFLWGLSCALPVA 
RYHNTESESSEER 
3778.9 3777.8 1-33 
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Figure 30 U2OS derived fDMP1 digested by trypsin. Coverage:30% 
Identified peptide Expected 
ms 
Observed ms Amino acid 
position 
GELTDSNSR 978.4 978.5 275-283 
GQYRPAGGLSK 1133.6 1133.6 80-90 
SQESQSEQDSR 1280.5 1280.5 429-439 
YHNTESESSEER 1467.6 1467.6 22-33 
ETQSDSTEDTASKEESR 1899.8 1899.8 284-300 
SKEESNSTGSASSSEEDIRP K 2225.0 2225.2 452-472 
GDREPTSTQDSDDSQSVEFS SR 2430.0 2430.1 239-260 
SQESQSEQDSRSEEDSDSQD SSR 2603.0 2603.0 429-451 
SEESKGDREPTSTQDSDDSQ SVEFSSR 2990.2 2990.3 234-260 
VGGGSEGESSHGDGSEFDDE 
GMQSDDPESTR 
3157.2 3157.2 189-219 
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Figure 31 U2OS derived fDMP1 digested by AspN. Coverage: 36% 
Identified peptide Expected ms Observed ms Aa  position 
DSNSRETQS 1023.4 1022.6 279-287 
DIRPKNMEA 1073.5 1073.6 468-476 
DTASKEESRSESQE 1582.7 1582.8 292-305 
DYRGELTDSNSRETQS 1857.8 1857.0 272-287 
DRGQYRPAGGLSKSTGTGA 1878.9 1879.1 78-96 
DSESEEQRVGGGSEGESSHG 2019.8 2020.0 181-200 
DSSRSKEESNSTGSASSSEE 2060.8 2061.0 448-467 
DSRKLIVDAYHNKPIGDQ 2069.1 2069.2 477-494 
DSSSQEGLQSQSASTESRSQ ESQSEQ 2787.2 2787.4 411-436 
DGDSSSQEGLQSQSASTESR SQESQSEQ 2959.2 2959.4 409-436 
DPSSESSEEAGEPSQESSSE 
SQEGVTSESRG 
3172.3 3172.5 321-351 
DSPEGQDPSSESSEEAGEPS 
QESSSESQEGVTSESRG 
3785.5 3785.7 315-351 
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Figure 32 MC3T3derived fDMP1 digested by Trypsin. Coverage:22% 
Identified peptide Expected 
ms 
Observed ms Amino acid 
position 
GQYRPAGGLSK 1133.6 1133.6 80-90 
SQESQSEQDSR 1280.5 1280.6 429-439 
SKEESNSTGSASSSEEDIRP K 2225.0 2225.2 452-472 
GDREPTSTQDSDDSQSVEFS SR 2430.0 2430.1 239-260 
SQESQSEQDSRSEEDSDSQD SSR 2603.0 2603.1 429-451 
SEESKGDREPTSTQDSDDSQ SVEFSSR 2990.3 2990.3 234-260 
VGGGSEGESSHGDGSEFDDE 
GM(O)QSDDPESTR 
3173.2 3173.3 189-219 
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Figure 33 MC3T3derived fDMP1 digested by AspN. Coverage: 19% 
Identified peptide Expected 
ms 
Observed ms Amino acid 
position 
DSTSQENSAQ 1066.4 1066.1 145-154 
DSESEEQRVGGGSEGESSHG 2019.8 2019.9 181-200 
DSSSQEGLQSQSASTESRSQ ESQSEQ 2787.2 2787.3 411-436 
DGDSSSQEGLQSQSASTESR SQESQSEQ 2959.2 2959.4 409-436 
DPSSESSEEAGEPSQESSSE 
SQEGVTSESRG 
3172.3 3172.5 321-351 
DSPEGQDPSSESSEEAGEPS 
QESSSESQEGVTSESRG 
3785.5 3785.8 315-351 
 
4.7 DISSCUSSION 
Osteoblast cells are a rich source of CKI and CKII activity[30], CKII was thought to be 
responsible for the phosphorylation of DPP[31] and DMP1 [28] from assays using CKII inhibitor, 
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however, no direct evidence has shown CKII’s involvement. Our zymogram data identified CKII 
subunit from cell lysates and confirms CKII’s role.  Our data also shows that CKI can in vitro 
phosphorylate DDP and DMP1 much better than CKII.  More attention should be dedicated to 
CKI’s role in mineralized tissues. Unphosphorylated DMP1 was shown to first localize in the 
nucleus, works as regulator of osteoblast-specific genes [32], during maturation transition of the 
osteoblast, DMP1 was shown to get phosphorylated and migrate to the extracellular matrix [28], 
correspondingly, our data shows nuclei fraction from MC3T3 cell lysates do have the ability to 
phosphoryalte DMP1. Under maturation transition conditions, the cells release calcium from 
their intracellular stores[33], and the export of DMP1 was found to be in response to the stimulus 
from Ca++, which might be transported through IP3/ryanodine receptors[34]. Our results further 
confirm the role of Ca++ by showing different phosphorylation levels corresponding to different 
Ca++ concentration.   
      Phosphorylation level of DMP1 is important for its function. The 57kD fragments of highly 
phosphorylated DMP1 works as a hydroxyapatite nucleator, while low level of phosphorylation  
of DMP1 has no effect on either hydroxyapatite proliferation or growth[35] . Although published 
data suggest CKII was the enzyme responsible for DMP1[28] , CKII could only phosphorylate 
DMP1 to a very low level (5 phosphate per DMP1) in vitro which couldn’t function as mineral 
nucleator[35]. Despite the difference in the in vitro vs. the cell phosphorylation, we hypothesized 
that there might be other kinases participating in DMP1 phosphorylation. Our zymogram data 
not only provided the list of possible novel kinases, but also showed similar kinases pattern of 
both MC3T3 and NIH3T3 cells, which emphasized that it is might not the kinase specificity but 
the regulation mechanism (e.g, Calcium flux[28]) which differ the DMP1’s phosphorylation and 
function. 
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4.8 SUMMARY AND FUTURE RESEARCH 
We successfully phosphorylated DMP1 and DPP in vitro. When DMP1was phosphorylated with 
CKI at 30oC for 1hour, we were able to quantify approximately 13 phosphates per molecule. It 
was difficult to quantify DPP’s phosphorylation due to the low binding of DPP to P81 paper. 
However, DPP’s phosphorylation level was higher compared to DMP1 when assessed by loading 
the phosphorylation reaction mix using radioactive 32[ATP] onto an SDS-PAGE gel . Different 
conditions (temperature, time points, Ca2+/Mg2+ ion concentration, enzymes) were assayed and 
we could obtain different phosphorylation level of DPP/DMP1by adjusting these conditions. 
When DMP1 was in vitro phosphorylated by CKI at 30oC for 1hour, we detected 6 phospho-
peptides and identified Ser66 as a phosphorylation site by mass spectrometry. 
            We found there is no kinase specificity for DMP1 phosphorylation in mineralizing or 
non-mineralizing tissues, at least 3 different (forms) enzymes from cell lysate were responsible 
for DMP1 phosphorylation, with molecular weights of 37kD, 40kD and 60kD, respectively. 
CKII catalytic subunit alpha was identified, which is the first direct evidence of CKII’s 
involvement in DMP1 phosphorylation. Some other possible novel kinases were identified from 
zymogram analysis, but most of them are not commercially available. Further research may be 
focus on purifying and confirming these kinases. 
          Cell derived phosphorylation were compared by over-expressing and purifying DMP1 
from mineralized and connective tissue cells. We couldn’t over-express DMP1 gene from 
NIH3T3 cells after trying several different conditions, perhaps in fibroblast cells there might be 
some degradation mechanism to eliminate proteins that can initiate mineralization. We were able 
to purify DMP1 from MC3T3, U2OS, HEK-293 cells, which are originated from tissues where 
DMP1 was found. Comparison of MC3T3 and HEK293 derived DMP1 show similar cleavage 
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and phosphorylation pattern; however, there seems to be more 37kD and 57kD fragments in 
MC3T3 derived DMP1 compared with HEK293; these fragments were functionally active while 
the whole DMP1 is inactive. [25] This might indicate the difference of corresponding proteinase 
activity regulated by mineralized and connective tissue cells. Due to the limitation of mass 
spectrometry to analyze phospho-clusters, the phosphate analysis and localization remain a 
challenge from cell derived DMP1; we will use Inductively Coupled Plasma (ICP) to quantify 
the  phosphate of these cell derived DMP1 and further analyze their role in mineralization.  
            Finally, we believe that the outcomes of this research will provide the basis to further 
assess the role of phosphorylation in mineralization. 
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